BioStabilization Systems (BoSS)
noticeId: aadd5b36db484e0a8f4e29d77af9f081
Typical award (median): $22,490,114
HEALTH AND HUMAN SERVICES, DEPARTMENT OF · NAICS 541715 · PSC AN13 · Solicitation ARPA-H-SOL-26-136
Status: ACTIVE
Posted: Dec 02, 2025, 05:31 PM UTC
Due: Mar 26, 2026, 09:00 PM UTC
Place of performance: Washington
Indexed last: Jan 26, 2026, 03:38 AM UTC
The BioStabilization Systems (BoSS) program aims to transform how live cell-based therapies are stabilized, manufactured, and distributed. At its core, BoSS addresses a foundational bottleneck in the delivery of advanced cell and gene therapies (CGTs): the critical dependence ...
Award history intel (last 12 months)
Match: NAICS n:541715
Deals found
2000+ (sampled)
Total obligation
$173,314,028,686
Unlock to get the full decision panel
Unlock shows pricing band (p25–p75), typical award, top winners, and concentration risk.
Teaser: Top winner holds 15% share (FLUOR MARINE PROPULSION, LLC).